• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE); SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number HGB161207A
Device Problems Stretched (1601); Patient-Device Incompatibility (2682); Device Damaged by Another Device (2915)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/16/2020
Event Type  Injury  
Event Description
On (b)(6) 2020, the patient was treated for an abdominal aortic aneurysm.The physician attempted to implant a gore® excluder® iliac branch endoprosthesis, but due to tortuosity of patient anatomy, was unable to deliver the device to the intended location.The physician attempted to remove the device, but in doing so, it became caught on the sheath.The device was finally removed, and the tube appeared stretched, but the olive did not detach.The physician completed the procedure using a vbx.The patient tolerated the procedure.The physician believes the event was caused by tortuosity of the patient's anatomy.A review of the manufacturing records for the device verified that the lot met all pre-release specifications.The device was returned for evaluation.The engineering evaluation stated: there was a gap between the leading olive and the undeployed stent graft.The polyimide guidewire lumen portion of the catheter was still bonded to the leading and trailing olives.The stent graft was still constrained on the catheter.There was damage on the trailing end of the leading olive consistent with the leading olive catching on the introducer sheath on withdrawal.The findings from the evaluation are consistent with the physician¿s observations.The cause for the device catching on the introducer sheath could not be determined from the currently available information.The reported tortuous anatomy may have contributed to the event.
 
Manufacturer Narrative
H1: type of report changed to: other.Upon receipt of the engineering evaluation, this event has been determined to be non-reportable, as there was no reported catheter breakage, shaft detachment, or olive separation occurring during the procedure.Therefore, medwatch (mfr.Report # 3013164176-2020-00050), is being retracted.
 
Manufacturer Narrative
H3: evaluation summary- the engineering evaluation stated; there was a gap between the leading olive and the undeployed stent graft.The polyimide guidewire lumen portion of the catheter was still bonded to the leading and trailing olives.The stent graft was still constrained on the catheter.There was damage on the trailing end of the leading olive consistent with the leading olive catching on the introducer sheath on withdrawal.The findings from the evaluation are consistent with the physician¿s observations.The cause for the device catching on the introducer sheath could not be determined from the currently available information.The reported tortuous anatomy may have contributed to the event.H6: results code 1 - corrected.H6: code 213 - review of the manufacturing records for the device verified that the lot met all pre-release specifications.H6: code 22 - according to the gore® excluder® iliac branch endoprosthesis instructions for use (ifu), additional considerations for patient selection include but are not limited to the patient¿s anatomical suitability for endovascular repair.Ilio-femoral access vessel size and morphology (minimal thrombus, calcium and/or tortuosity) should be compatible with vascular access techniques and the vascular introducer sheaths and accessories necessary to deliver the endoprostheses.Further, the ifu cautions do not attempt to withdraw any undeployed endoprosthesis through the introducer sheaths.The sheath and undeployed device catheter must be removed together.Catheter breakage or separation or premature deployment have occurred and may result in potential patient harms.Do not continue to withdraw the delivery catheter if resistance is felt during removal through the introducer sheath.Forcibly withdrawing the delivery catheter through the introducer sheath when resistance is encountered has resulted in adverse events including catheter breakage or separation and reintervention resulting in potential patient harm.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AORTIC EXCLUDER ILIAC BRANCH ENDOPROSTHESIS (IBE)
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key9941065
MDR Text Key190314686
Report Number3013164176-2020-00050
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132635320
UDI-Public00733132635320
Combination Product (y/n)N
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 10/28/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/08/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/10/2022
Device Model NumberHGB161207A
Device Catalogue NumberHGB161207A
Device Lot Number21444450
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/24/2020
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age76 YR
-
-